Your body needs to adapt to the glucagon receptor activation specifically, and no amount of GLP-1 tolerance from semaglutide or GLP-1/GIP tolerance from tirzepatide prepares you for that third receptor pathway
They share a mechanism both are growth hormone-releasing hormone (GHRH) analogs that stimulate your pituitary gland to produce more of its own GH but the intensity, clinical profile, and ideal use case for each are meaningfully different
Certain amino acids, particularly cysteine, are crucial for glutathione synthesis
When these energy factories are shielded from oxidative damage, they produce ATP more efficiently
All together this program is very beneficial in improving Chronic Fatigue symptoms
doi: 10.3389/fcell.2025.1525294 Received 09 November 2024 Accepted 14 February 2025 Published 05 March 2025 Volume 13 - 2025 Edited by Patrice X